1.
The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial
by Dowman, Leona M
Thorax, 2017, Vol.72 (7), p.610-619
2.
Interstitial lung disease in connective tissue disorders
by Fischer, Aryeh, MD
The Lancet (British edition), 2012, Vol.380 (9842), p.689-698
3.
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Glob...
by Abd-Allah, Foad
The Lancet (British edition), 2017, Vol.390 (10100), p.1211-1259
4.
5.
Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience
by Chartrand, Sandra
Respiratory medicine, 2016, Vol.119, p.150-154
6.
Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study
by Guerra, Stefano
Thorax, 2010, Vol.65 (6), p.499-504
7.
Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer
by Kato, Terufumi
Lung cancer (Amsterdam, Netherlands), 2017, Vol.104, p.111-118
8.
Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study
by Enomoto, Yasunori
Respiratory medicine, 2017, Vol.133, p.1-5
9.
Heterogeneity of lung disease associated with NK2 homeobox 1 mutations
by Nattes, Elodie
Respiratory medicine, 2017, Vol.129, p.16-23
10.
Stroke-Associated Pneumonia: Major Advances and Obstacles
by Hannawi, Yousef
Cerebrovascular diseases (Basel, Switzerland), 2013, Vol.35 (5), p.430-443
11.
Pulmonary interstitial glycogenosis – A systematic analysis of new cases
by Seidl, E
Respiratory medicine, 2018, Vol.140, p.11-20
12.
The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire
by Patel, Amit S
Thorax, 2012, Vol.67 (9), p.804-810
13.
Listeria monocytogenes-associated respiratory infections: a study of 38 consecutive cases
by Morgand, M
Clinical microbiology and infection, 2018, Vol.24 (12), p.1339.e1-1339.e5
14.
15.
Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis
by Rojas-Serrano, Jorge
Clinical rheumatology, 2017, Vol.36 (7), p.1493-1500
16.
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016:...
by Abate, Kalkidan Hassen
The Lancet (British edition), 2017, Vol.390 (10100), p.1260-1344
17.
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
by Shaverdian, Narek, MD
The lancet oncology, 2017, Vol.18 (7), p.895-903
18.
Risk of interstitial lung disease with gefitinib and erlotinib in advanced non-small cell lung cancer: A systematic review and meta-analysis of clinical trials
by Shi, Liang
Lung cancer (Amsterdam, Netherlands), 2013, Vol.83 (2), p.231-239
19.
Lung function and cardiovascular disease: A link
by Ramalho, Sergio H.R
Trends in cardiovascular medicine, 2021, Vol.31 (2), p.93-98
20.
Pulmonary interstitial glycogenosis associated with a spectrum of neonatal pulmonary disorders
by Cutz, Ernest
Human pathology, 2017, Vol.68, p.154-165
